2seventy bio, Inc. Contracts & Agreements
36 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (4)
- Human Resources (15)
- Intellectual Property (5)
- Uncategorized (5)
- Asset Purchase Agreement between 2seventy bio, Inc. and Novo Nordisk A/S, dated as of June 21, 2024 (Filed With SEC on August 8, 2024)
- Asset Purchase Agreement between 2seventy bio, Inc. and Regeneron Pharmaceuticals, Inc., dated as of January 29, 2024 (Filed With SEC on May 9, 2024)
- Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (Filed With SEC on April 1, 2024)
- Amended and Restated Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of March 29, 2024 (incorporated by reference to the Current Report on... (Filed With SEC on April 1, 2024)
- Release and Equity Agreement, by and between 2seventy bio, Inc. and Philip Gregory (Filed With SEC on March 18, 2024)
- Second Amendment to License Agreement, dated January 16, 2024, by and between 2seventy bio, Inc. and the National Institutes of Health (Filed With SEC on March 7, 2024)
- Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Executive Employment Agreement between 2seventy bio, Inc. and William Baird, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Executive Employment Agreement between 2seventy bio, Inc. and Victoria Eatwell, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Second Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement, between 2seventy bio, Inc., Celgene Corporation and Celgene Investment Company LLC,... (Filed With SEC on August 14, 2023)
- License Agreement by and between bluebird bio, Inc. and Institut Pasteur, dated September 8, 2011, as amended (Filed With SEC on May 10, 2023)
- Consulting Agreement between 2seventy bio, Inc. and Nicola Heffron, dated February 21, 2023 (Filed With SEC on March 16, 2023)
- Severance Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated February 17, 2023 (Filed With SEC on March 16, 2023)
- Underwriting Agreement, dated as of February 28, 2023, by and between the Company and Goldman Sachs & Co. LLC, Cowen and Company, LLC, and SVB Securities LLC, as representatives... (Filed With SEC on March 1, 2023)
- Sales Agreement, dated November 18, 2022 between 2seventy bio, Inc. and Cowen and Company, LLC (Filed With SEC on November 18, 2022)
- Second Addendum to Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of March 25, 2022 (Filed With SEC on May 12, 2022)
- Amendment to License Agreement, dated April 25, 2022, by and between 2seventy bio, Inc. and the National Institutes of Health (Filed With SEC on May 12, 2022)
- Patent License Agreement, dated August 31, 2015, by and between bluebird bio, Inc. and the National Institutes of Health (Filed With SEC on May 12, 2022)
- First Addendum Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of March 7, 2022 (Filed With SEC on May 12, 2022)
- Amendment to Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of December 8, 2021 (Filed With SEC on March 22, 2022)
- Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of December 1, 2021 (Filed With SEC on March 22, 2022)
- Letter Agreement between 2seventy bio, Inc. and Nicola Heffron, dated as of November 8, 2021 (Filed With SEC on March 22, 2022)
- 2seventy bio, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 22, 2022)
- Description of Securities (Filed With SEC on March 22, 2022)
- Form of Registration Rights Agreement (Filed With SEC on March 16, 2022)
- Form of Share Purchase Agreement (Filed With SEC on March 16, 2022)
- Tax Matters Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Separation Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Employee Matters Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Intellectual Property License Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Transition Services Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Transition Services Agreement, dated as of November 3, 2021, by and between 2seventy bio, Inc. and bluebird bio, Inc (Filed With SEC on November 4, 2021)
- Assumption Agreement, dated as (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and Nick Leschly (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and William Baird (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and Philip Gregory (Filed With SEC on November 4, 2021)
